GFAP Alternative Splicing and the Relevance for Disease - A Focus on Diffuse Gliomas

Publication date

2022-06-09

Authors

van Asperen, Jessy V.
Robe, Pierre A J T
Hol, EllyORCID 0000-0001-5604-2603

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by_nc

Abstract

Glial fibrillary acidic protein (GFAP) is an intermediate filament protein that is characteristic for astrocytes and neural stem cells, and their malignant analogues in glioma. Since the discovery of the protein 50 years ago, multiple alternative splice variants of the GFAP gene have been discovered, leading to different GFAP isoforms. In this review, we will describe GFAP isoform expression from gene to protein to network, taking the canonical isoforms GFAPα and the main alternative variant GFAPδ as the starting point. We will discuss the relevance of studying GFAP and its isoforms in disease, with a specific focus on diffuse gliomas.

Keywords

Alternative Splicing/genetics, Astrocytes/metabolism, Glial Fibrillary Acidic Protein/genetics, Glioma/genetics, Humans, Intermediate Filaments/metabolism, Protein Isoforms/genetics, cytoskeleton, glia, GFAP, glioma, splicing, astrocyte, Clinical Neurology, General Neuroscience, Review, Research Support, Non-U.S. Gov't, Journal Article

Citation

van Asperen, J V, Robe, P A J T & Hol, E M 2022, 'GFAP Alternative Splicing and the Relevance for Disease - A Focus on Diffuse Gliomas', ASN neuro, vol. 14, pp. 1-18. https://doi.org/10.1177/17590914221102065